ABUS
Arbutus Biopharma CorporationHealthcare$4.48
▲ Bullish
Mkt Cap: $875.7M|Float: 127.7M|SI: 12.8%|DTC: 6.3
Data as of market close Apr 2, 2026
IV Rank
95
IV Pctl
75%
HV 20d
54.1%
52W Range
$3-$5
ATR(14)
$0.22
Exp. Move
±13.4%
P/C Ratio
0.75
Earnings
May 13
GEX Positive
DEX Long
Net Put Premium
IV High
Max Pain Above
Exp. Move Wide
ABUS Key Options Data
- IV Rank
- 95.2%
- Total GEX
- $0.00B
- Total DEX
- $0.7M
- Max Pain
- $5.00
- Expected Move
- ±13.4%
- Put/Call OI
- 0.75
- Net Premium
- $-0.1M
- Spot Price
- $4.48
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$0.60 | ±13.4% | $3.88 | $5.08 |
| 2026-06-18 | 77 | ±$1.72 | ±38.5% | $2.76 | $6.21 |
| 2026-09-18 | 169 | ±$1.40 | ±31.3% | $3.08 | $5.88 |
| 2027-01-15 | 288 | ±$2.70 | ±60.3% | $1.78 | $7.18 |
Explore ABUS options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.